Pharma Pulse 10/4/24: What Does ‘Third Age’ Look Like, Health Insurance You Haven’t Heard Of & more

What Does the ‘Third Age’ Look Like for BioPharma Employees as They Plan for Longer Life Spans?

Ken Dychtwald, PhD, is the founder and CEO of Age Wave, an acclaimed think tank and consultancy focused on the social and business implications and opportunities of global aging and rising longevity. His client list has included over half of the Fortune 500. Dychtwald has served as a fellow of the World Economic Forum and was a featured speaker at two White House Conferences on Aging.

The Type of Health Insurance You Haven’t Heard Of

Individual coverage health reimbursement arrangements (ICHRAs) let employees pick their health insurance policy.

Pay Rises for Cyber Chiefs as Hacks, Regulatory Pressure Increase

Average compensation for U.S.-based chief information security officers is now $565,000.

Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer

PharmaJet® announced that Wouter Latour, M.D., has joined the company as Chief Executive Officer (CEO). Latour also joins the PharmaJet board of directors. He succeeds Chris Cappello who has recently been elected Vice-Chairman of the Board and will remain active in the business, largely focused on strategic partners and supporting engineering/operations.

Nicholas Saraceno on LinkedIn

We've been rolling out Pharmaceutical Commerce Magazine's October content bit by bit, and one of those articles is penned by Amy Niles of the PAN Foundation in her "Healthcare Reform" column. She does a wonderful job outlining two of the IRA’s most important provisions that will go into effect on Jan. 1, 2025—a $2,000 cap on OOP drug spending for all individuals with a Part D plan, and the opportunity to opt-in to the Medicare Prescription Payment Plan and spread costs throughout the year.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs